Urinary tract infection (UTI) is the most common infectious complications after renal transplantation. Recently many researchers reported that the bacterial agents of UTI in renal allograft recipients changed and demonstrated increased antimicrobial resistance to commonly used cephalosporins. This study was undertaken to isolate the bacteria which are responsible for UTI and their susceptibility pattern for appropriate antibiotic therapy in renal allograft recipients. This was an observational study conducted in the Department of Microbiology Bangabandhu Sheikh Mujib Medical University (BSMMU) from December 2010 to 2011. Twenty one renal allograft recipients from Department of Nephrology were evaluated for UTI after surgery up to six weeks. Microscopic examination, culture and sensitivity of urine specimen were performed. Out of 21 renal allograft recipients, 13(61.90%) patients developed UTI during initial post transplant period. Of 69 urine specimens collected from them 22(31.88%) yielded positive results for culture. Enterococcus spp. (50%) was the major bacterial pathogen isolated and showed 100% resistance to Cefuroxime, Ceftriaxone and Ceftazidime. Enterococcus spp. is an emerging pathogen responsible for development of UTI in renal allograft recipients which showed 100% resistance to 2nd and 3rd genaration cephalosporin group.
Introduction:
Urinary tract infection (UTI) is the most common infection following renal transplantation 1 .The reported incidence of post transplantation UTI varies considerably from 10 to 98% 2 . Differences in the definition of UTI, follow-up period, time of testing and the use of antimicrobial prophylaxis may explain this wide range 3 . Previously bacterial agents isolated from renal transplant recipients with UTI were almost similar to those causing UTI in the general population 4 . In Bangabandhu Sheikh Mujib Medical University (BSMMU) over a period of 2 years from January 2002 to December 2003 Islam et al 5 studied 31 post renal transplant patients of which 51 episodes of bacterial infection occur. Among them UTIs account for 49 episodes (96%) and most of the isolated organism were Gram negative Escherichia coli (88%) 5 . Iqbal et al 6 in Karachi 2010 reported 51(77%) patients suffered from UTIs among 66(33%) renal transplant recipients and gram negative bacilli were the principal isolates. Enterococcus spp. is gram positive cocci that have emerged, over the last decades, as very important nosocomial pathogen causing UTIs 7 . Their ability to form biofilm is of particular importance in the development of UTI especially in catheterized patients 8 susceptibility pattern of the infecting microorganisms have been suggested to guide an appropriate antibiotic therapy in post renal transplant patients 10 . The prevalence of drug resistance varies considerably by region and country, thus awareness of local and regional antibiotic susceptibility among uropathogen is recommended to optimize empiric treatment 11 . We assume that, due to social, financial and environmental differences between countries and different transplant centre, the post transplant infectious pattern may be different too; so aims of this study was to find out bacterial agents of UTI and their antimicrobial resistance pattern in post renal transplant patients. The outcome of the study could help in the treatment of post transplant UTIs in our community and that may help to increase the chance of graft survival.
Methods:
This was an observational study carried out in the Department of Microbiology BSMMU, Shahbagh, Dhaka, Bangladesh from December 2010 to December 2011. A total 21 renal allograft recipients from the department of Nephrology, BSMMU were evaluated for UTI and their antimicrobial resistance pattern were determined. First urine specimens were taken from each patient in preoperative period for screening. Second and third specimens were directly taken from the catheter on 3rd and 7th post operative day & fourth specimens were taken within six weeks.
Urinary studies: Clean catch midstream urine in pre operative patients and with proper aseptic preparation from catheterized patients were collected for study. Urinary quantitative culture was performed on Chromoagar media. It was considered a positive result for urinary tract infection (UTI) when bacterial counts were recorded up to 10 3 or more per ml of urine 12, 13 . Isolated Gram negative and Gram positive organisms were identified by standard phenotypic detection methods. showed 90%, 27% and 9% resistance against gentamicin, netilmicin and imipenem respectively (Figure -1) . Escherichia coli, Klebsiella, Enterobacter spp. all showed 100% resistance to cephalosporin and ciprofloxacin except Klebsiella which was 50% resistant to ciprofloxacin (Table-2) . Pseudomonas, Acinetobacter spp. also showed resistance to cephalosporin and ciprofloxacin but sensitivity showed against amikacin, imipenem and piperacillin/ tazobactum. Staph. epidremidis was sensitive to vancomycin and showed resistance to co-trimoxazole, cephradine and amoxyclave. 
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Discussion:
Infections are the major determinant of the outcome of renal transplantation 16 . In this observational study, UTI developed in most of the patients (61.90%) within 6th weeks of renal transplantation. This finding was in almost consistent with the findings of the studies by Iqbal et al 6 5 in 2011 found that all isolates were sensitive to ceftriaxone, ceftazidime and ciprofloxacin which was not consistent with present study. This marked variation in the sensitivity pattern between these studies might be due to difference in antibiotic prescription pattern. On the other hand Imipenem, netilmycin, and piperacillin / tazobactum have shown better sensitivity in almost all organisms in present study because these antibiotics are costly and used less frequently.In our hospital ( from where have recruited out study population) 3rd generation cephalosporins are the most commonly used antibiotic. Enterococcus spp. (50%) has emerged as the major pathogen responsible for UTI in renal transplanted patient which showed resistance to 2nd and 3rd genaration cephalosporin group. Imipenem and netilmicin is the choice of therapeutic alternative.
